產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CCDC116抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CCDC116抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CCDC116
Cat. Number:
Anti-CCDC116抗體KL-8111R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CCDC116 is a 515 amino Anti-CCDC116抗體acid protein that exists as two alternatively spliced isoforms. Encoded by a gene that maps to human chromosome 22q11.21, CCDC116 is induced by curcumin (diferulolylmethane), although its role is unclear. CCDC116 is significantly affected by dietary curcumin, which may have a protective role in inflammatory bowel disease (IBD) and may reduce the relapse rate in human ulcerative colitis (UC). As the second smallest human chromosome, chromosome 22 contains over 500 genes and about 49 million bases. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocation between chromosomes 9 and 22 may lead to the formation of Philadelphia Chromosome and subsequent production of a novel fusion protein known as BCR-Abl, a potent cell proliferation activator found in several types of leukemia.
Also known as:
CC116_HUMAN; Ccdc116; Anti-CCDC116抗體Coiled-coil domain-containing protein 116.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from Human CCDC116.
●
Predicted Molecular Weight: 57kDa.
Storage:
Shipped at 4℃, StoreAnti-CCDC116抗體 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-CCDC116抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-CCDC116抗體dilutions must be determined by the end user.
kl628Ra01 一氧化氮合酶運(yùn)輸因子(NOSTRIN)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase Trafficker (NOSTRIN)
kl629Hu01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl629Mu01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl629Ra01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl630Hu01 糖原合酶激酶3α(GSK3α)多克隆抗體 Polyclonal Antibody to Glycogen Synthase Kinase 3 Alpha (GSK3a)
kl630Ra01 糖原合酶激酶3α(GSK3α)多克隆抗體 Polyclonal Antibody to Glycogen Synthase Kinase 3 Alpha (GSK3a)
kl631Hu01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl631Mu01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl631Ra01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl635Hu01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
kl635Mu01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
kl635Ra01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
kl636Hu01 成纖維細(xì)胞生長(zhǎng)因子7(FGF7)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 7 (FGF7)
kl636Mu01 成纖維細(xì)胞生長(zhǎng)因子7(FGF7)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 7 (FGF7)
kl636Po01 成纖維細(xì)胞生長(zhǎng)因子7(FGF7)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 7 (FGF7)
kl636Ra01 成纖維細(xì)胞生長(zhǎng)因子7(FGF7)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 7 (FGF7)
kl637Hu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Mu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
